phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

New Study Unveils Clues to 'Exceptional' Response in Metastatic Kidney Cancer Immunotherapy

Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, historically has presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, can lead to exceptional, durable responses (when the tumor substantially shrinks for a very long period of time) for some patients with mccRRC, allowing them to live longer with a better quality of life.

January 9, 2025


January 9 2025

January 8 2025

January 7 2025

January 6 2025

January 4 2025

January 3 2025

January 2 2025

January 1 2025

December 31 2024

December 30 2024

December 29 2024

December 28 2024

December 27 2024

Angell Street Psychiatry
Copyright 2025 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy